Stockreport

ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab demonstrated highly statistically significant and clinically meaningful improvement in progression-free survival vs. THP as 1st-l...

AstraZeneca PLC - American Depositary Shares  (AZN) 
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm Check Earnings Report
US:NYSE Investor Relations: astrazeneca.com/investor-relations.html
PDF across a broad HER2-positive metastatic patient population versus current 1st-line standard of care WILMINGTON, Del., April 21, 2025 BUSINESS WIRE )--Positive high-lev [Read more]